Skip to main content
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest
  • facebook
  • twitter
  • linkedin
  • youtube
Home
  • About
    • About the Navigator
    • Navigator FAQs
  • Guides
    • For Patients and Caregivers
    • For Physicians and Healthcare Providers
    • For Companies and Sponsors
  • Company Directory
    • View Company Directory
    • Submit Company Information
  • Resources
  • Expanded Access eRequest

Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19

  • Read more about Retinal Neurovascular Coupling in Patients Previously Infected With COVID-19

A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination

  • Read more about A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination

Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5)

  • Read more about Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5)

Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell Impairment

  • Read more about Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell Impairment

A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19

  • Read more about A Study to Compare QLS1128 With Placebo in Symptomatic Participants With Mild to Moderate COVID-19

Assessment of Immunogenicity, Safety and Reactogenicity of a Booster Dose of Various COVID-19 Vaccine Platforms in Individuals Primed With Several Regimes.

  • Read more about Assessment of Immunogenicity, Safety and Reactogenicity of a Booster Dose of Various COVID-19 Vaccine Platforms in Individuals Primed With Several Regimes.

Treatment Use of the CliniMACS® CD34 TCR Alpha/Beta for Allogenic Transplant (Expanded Access Use)

  • Read more about Treatment Use of the CliniMACS® CD34 TCR Alpha/Beta for Allogenic Transplant (Expanded Access Use)

Digital Cognition Study During Long-COVID

  • Read more about Digital Cognition Study During Long-COVID

Unleash the Mystery of COVID-19 Related Unusual Thrombosis

  • Read more about Unleash the Mystery of COVID-19 Related Unusual Thrombosis

GlycoMimetics, Inc.

By jpalfreyman on Fri, 04/26/2024 - 13:54
  • Read more about GlycoMimetics, Inc.

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 70
  • Page 71
  • Page 72
  • Page 73
  • Current page 74
  • Page 75
  • Page 76
  • Page 77
  • Page 78
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Subscribe for updates from the Reagan-Udall Foundation for the FDA

Subscribe
(202) 849 - 2075
1333 New Hampshire Ave, NW
Suite 420
Washington, DC 20036
navigator@reaganudall.org
  • facebook
  • twitter
  • linkedin
  • youtube

© Reagan-Udall Foundation for the FDA
© Reagan-Udall Foundation for the FDA